CN104645192A - Chinese medicine composition for treating prostatitis - Google Patents
Chinese medicine composition for treating prostatitis Download PDFInfo
- Publication number
- CN104645192A CN104645192A CN201510135572.5A CN201510135572A CN104645192A CN 104645192 A CN104645192 A CN 104645192A CN 201510135572 A CN201510135572 A CN 201510135572A CN 104645192 A CN104645192 A CN 104645192A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- rhizoma
- chinese medicine
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Chinese medicine composition for treating prostatitis. The Chinese medicine composition is prepared from the following raw materials in parts by weight: 22-28 parts of Codonopsis pilosula, 22-28 parts of Astragalus membranaceus, 22-28 parts of salviae miltiorrhizae, 22-28 parts of leonurus, 13-17 parts of rheum officinale, 13-17 parts of achyranthes bidentata, 13-17 parts of radix paeoniae alba, 13-17 parts of Rhizoma Atractylodis Macrocephalae, 13-17 parts of yam rhizome, 13-17 parts of herba epimedii, 13-17 parts of Polygonum cuspidatum, 6-8 parts of akebiaquinata, 6-8 parts of rush, 6-8 parts of fructus alpiniae oxyphyllae, 6-8 parts of rhizoma acori graminei, 6-8 parts of dogwood, 2-4 parts of pittosporum root, 2-4 parts of fennel, 2-4 parts of amber and 2-4 parts of daemonorops draco. The Chinese medicine composition disclosed by the invention has the advantages that the efficacy is obvious and the side effect is little.
Description
Technical field
The present invention relates to technical field of Chinese medicines, particularly relate to one and treat prostatitic Chinese medicine composition.
Background technology
Prostatitis is a kind of common male urinary system disease, is more common in person between twenty and fifty, in Urology Surgery male patient the right side of fifty, account for first place.Cardinal symptom has frequent micturition, urgent micturition, dribbling urination not to the utmost, and when urinating or defecate, urethral orifice adularescent paste, matter stick greasy secretions, and hyposexuality and seminal emission etc.Primary disease is many to be caused caused by the intrusion bodies of gland such as antibacterial, virus, mycoplasma, chlamydia because of reasons such as sexual life is unclean, acute urethritis, perineal position damages.
At present, treatment prostatitis mostly is antibacterial, antiinflammatory, analgesic drug product are main, and it exists the deficiencies such as unsatisfactory curative effect, side effect are large.
Summary of the invention
The technical problem to be solved in the present invention is: for solving the deficiencies in the prior art, the invention provides one and treat prostatitic Chinese medicine composition, the present invention has evident in efficacy, that side effect is little advantage.
One treats prostatitic Chinese medicine composition, be made up of the crude drug of following weight portion: Radix Codonopsis 22-28 part, Radix Astragali 22-28 part, Radix Salviae Miltiorrhizae 22-28 part, Herba Leonuri 22-28 part, Radix Et Rhizoma Rhei 13-17 part, Radix Achyranthis Bidentatae 13-17 part, Radix Paeoniae Alba 13-17 part, Rhizoma Atractylodis Macrocephalae 13-17 part, Rhizoma Dioscoreae Septemlobae 13-17 part, Herba Epimedii 13-17 part, Rhizoma Polygoni Cuspidati 13-17 part, Caulis Akebiae 6-8 part, Medulla Junci 6-8 part, Fructus Alpiniae Oxyphyllae 6-8 part, Rhizoma Acori Graminei 6-8 part, Radix Linderae 6-8 part, Radix Bupleuri 6-8 part, Semen Plantaginis 6-8 part, Rhizoma Corydalis 6-8 part, Rhizoma Dioscoreae 6-8 part, Fructus Corni 6-8 part, Radix Pittospori Glabrati 2-4 part, Fructus Foeniculi 2-4 part, succinum 2-4 part, Sanguis Draxonis 2-4 part.
The prostatitic Chinese medicine composition of described treatment, it is preferably: be made up of the crude drug of following weight portion: Radix Codonopsis 25 parts, the Radix Astragali 25 parts, Radix Salviae Miltiorrhizae 25 parts, Herba Leonuri 25 parts, Radix Et Rhizoma Rhei 15 parts, Radix Achyranthis Bidentatae 15 parts, the Radix Paeoniae Alba 15 parts, the Rhizoma Atractylodis Macrocephalae 15 parts of, Rhizoma Dioscoreae Septemlobae 15 parts, Herba Epimedii 15 parts, Rhizoma Polygoni Cuspidati 15 parts, Caulis Akebiae 7 parts, Medulla Junci 7 parts, Fructus Alpiniae Oxyphyllae 7 parts, Rhizoma Acori Graminei 7 parts, the Radix Linderae 7 parts, Radix Bupleuri 7 parts, Semen Plantaginis 7 parts, Rhizoma Corydalis 7 parts, Rhizoma Dioscoreae 7 parts, Fructus Corni 7 parts, Radix Pittospori Glabrati 3 parts, Fructus Foeniculi 3 parts, succinum 3 parts, Sanguis Draxonis 3 parts.
The preparation method of the prostatitic Chinese medicine composition of described treatment, Chinese medicinal preparation method is routinely made and is suitable for medicinal oral drugs.
The beneficial effect that the present invention is compared with prior art had is: the present invention is under Traditional Chinese medical theory and clinical experience instruct, and chooses each crude drug and proportioning thereof, has the function of eliminating damp-heat, Yishen Jianpi, reaches the prostatitic object for the treatment of.
Below in conjunction with clinical experiment, beneficial effect of the present invention is described:
(1) clinical data: the present invention treat altogether prostatitis patient 31 example, the age be 23-52 year.
(2) Therapeutic Method: the oral drugs that Chinese medicine composition of the present invention is made can be decoction, tablet, pill and capsule etc.For decoction, every day 1 pair, divide and take for 2 times, early, evening respectively takes 1 time, within 15 days, is 1 course for the treatment of.
(3) the standard of curative effect evaluation:
Cure: transference cure, examination of prostatic fluid is normal;
Take a turn for the better: symptom and sign improves, examination of prostatic fluid takes a turn for the better;
Do not heal: symptom and examination of prostatic fluid are without improvement.
(4) therapeutic outcome: the present invention treats prostatitis patient 31 example altogether, through 2-4 course of therapy, cures 29 examples, accounts for 93.5%, and take a turn for the better 2 examples, and account for 6.5%, effective percentage is 100%, has no any side effect.Cure in 29 examples, 2 courses for the treatment of cure 10 examples, and 3 courses for the treatment of cure 12 examples, and 4 courses for the treatment of cure 7 examples.Result shows, of the present invention have evident in efficacy, that side effect is little advantage.
(5) model case
1, often so-and-so, 52 years old, suffer from prostatitis, cardinal symptom be frequent micturition, urgent micturition, urine are waited for, nocturia increases, irritated with soreness of the waist and knees, hectic fever night sweat, xerostomia.Obviously improve after using 2 courses for the treatment of of Chinese medicine composition of the present invention, 4 recoveries from illness courses for the treatment of, follow up a case by regular visits to and do not recur for 1 year.
2, what certain, 27 years old, suffer from prostatitis, cardinal symptom is that perineum and lower abdomen pain are uncomfortable, rectal tenesmus, spiritlessness and weakness, tired after exacerbation of symptoms.Fully recover after using 2 courses for the treatment of of Chinese medicine composition of the present invention, follow up a case by regular visits to and do not recur half a year.
3, season so-and-so, 38 years old, suffer from prostatitis, cardinal symptom was frequent micturition, urgent micturition, nocturia increase, and has burning sensation, and existing dizzy, lethargy, perineum, testis have falling inflation pain.After 1 course for the treatment of of Chinese medicine composition of invention, symptom is obviously improved, and 3 recoveries from illness courses for the treatment of, follow up a case by regular visits to and do not recur for 1 year.
Detailed description of the invention
Embodiment 1:
One treats prostatitic Chinese medicine composition, is made up of the crude drug of following weight portion: Radix Codonopsis 25 parts, the Radix Astragali 25 parts, Radix Salviae Miltiorrhizae 25 parts, Herba Leonuri 25 parts, Radix Et Rhizoma Rhei 15 parts, Radix Achyranthis Bidentatae 15 parts, the Radix Paeoniae Alba 15 parts, the Rhizoma Atractylodis Macrocephalae 15 parts of, Rhizoma Dioscoreae Septemlobae 15 parts, Herba Epimedii 15 parts, Rhizoma Polygoni Cuspidati 15 parts, Caulis Akebiae 7 parts, Medulla Junci 7 parts, Fructus Alpiniae Oxyphyllae 7 parts, Rhizoma Acori Graminei 7 parts, the Radix Linderae 7 parts, Radix Bupleuri 7 parts, Semen Plantaginis 7 parts, Rhizoma Corydalis 7 parts, Rhizoma Dioscoreae 7 parts, Fructus Corni 7 parts, Radix Pittospori Glabrati 3 parts, Fructus Foeniculi 3 parts, succinum 3 parts, Sanguis Draxonis 3 parts.
The preparation method of the prostatitic Chinese medicine composition of described treatment, Chinese medicinal preparation method is routinely made and is suitable for medicinal oral drugs.
Embodiment 2:
One treats prostatitic Chinese medicine composition, is made up of the crude drug of following weight portion: Radix Codonopsis 22 parts, the Radix Astragali 22 parts, Radix Salviae Miltiorrhizae 22 parts, Herba Leonuri 22 parts, Radix Et Rhizoma Rhei 13 parts, Radix Achyranthis Bidentatae 13 parts, the Radix Paeoniae Alba 13 parts, the Rhizoma Atractylodis Macrocephalae 13 parts of, Rhizoma Dioscoreae Septemlobae 13 parts, Herba Epimedii 13 parts, Rhizoma Polygoni Cuspidati 13 parts, Caulis Akebiae 6 parts, Medulla Junci 6 parts, Fructus Alpiniae Oxyphyllae 6 parts, Rhizoma Acori Graminei 6 parts, the Radix Linderae 6 parts, Radix Bupleuri 6 parts, Semen Plantaginis 6 parts, Rhizoma Corydalis 6 parts, Rhizoma Dioscoreae 6 parts, Fructus Corni 6 parts, Radix Pittospori Glabrati 2 parts, Fructus Foeniculi 2 parts, succinum 2 parts, Sanguis Draxonis 2 parts.
The preparation method of the prostatitic Chinese medicine composition of described treatment, Chinese medicinal preparation method is routinely made and is suitable for medicinal oral drugs.
Embodiment 3:
One treats prostatitic Chinese medicine composition, is made up of the crude drug of following weight portion: Radix Codonopsis 28 parts, the Radix Astragali 28 parts, Radix Salviae Miltiorrhizae 28 parts, Herba Leonuri 28 parts, Radix Et Rhizoma Rhei 17 parts, Radix Achyranthis Bidentatae 17 parts, the Radix Paeoniae Alba 17 parts, the Rhizoma Atractylodis Macrocephalae 17 parts of, Rhizoma Dioscoreae Septemlobae 17 parts, Herba Epimedii 17 parts, Rhizoma Polygoni Cuspidati 17 parts, Caulis Akebiae 8 parts, Medulla Junci 8 parts, Fructus Alpiniae Oxyphyllae 8 parts, Rhizoma Acori Graminei 8 parts, the Radix Linderae 8 parts, Radix Bupleuri 8 parts, Semen Plantaginis 8 parts, Rhizoma Corydalis 8 parts, Rhizoma Dioscoreae 8 parts, Fructus Corni 8 parts, Radix Pittospori Glabrati 4 parts, Fructus Foeniculi 4 parts, succinum 4 parts, Sanguis Draxonis 4 parts.
The preparation method of the prostatitic Chinese medicine composition of described treatment, Chinese medicinal preparation method is routinely made and is suitable for medicinal oral drugs.
Claims (3)
1. the prostatitic Chinese medicine composition for the treatment of, it is characterized in that: be made up of the crude drug of following weight portion: Radix Codonopsis 22-28 part, Radix Astragali 22-28 part, Radix Salviae Miltiorrhizae 22-28 part, Herba Leonuri 22-28 part, Radix Et Rhizoma Rhei 13-17 part, Radix Achyranthis Bidentatae 13-17 part, Radix Paeoniae Alba 13-17 part, Rhizoma Atractylodis Macrocephalae 13-17 part, Rhizoma Dioscoreae Septemlobae 13-17 part, Herba Epimedii 13-17 part, Rhizoma Polygoni Cuspidati 13-17 part, Caulis Akebiae 6-8 part, Medulla Junci 6-8 part, Fructus Alpiniae Oxyphyllae 6-8 part, Rhizoma Acori Graminei 6-8 part, Radix Linderae 6-8 part, Radix Bupleuri 6-8 part, Semen Plantaginis 6-8 part, Rhizoma Corydalis 6-8 part, Rhizoma Dioscoreae 6-8 part, Fructus Corni 6-8 part, Radix Pittospori Glabrati 2-4 part, Fructus Foeniculi 2-4 part, succinum 2-4 part, Sanguis Draxonis 2-4 part.
2. the prostatitic Chinese medicine composition for the treatment of according to claim 1, is characterized in that: be made up of the crude drug of following weight portion: Radix Codonopsis 25 parts, the Radix Astragali 25 parts, Radix Salviae Miltiorrhizae 25 parts, Herba Leonuri 25 parts, Radix Et Rhizoma Rhei 15 parts, Radix Achyranthis Bidentatae 15 parts, the Radix Paeoniae Alba 15 parts, the Rhizoma Atractylodis Macrocephalae 15 parts of, Rhizoma Dioscoreae Septemlobae 15 parts, Herba Epimedii 15 parts, Rhizoma Polygoni Cuspidati 15 parts, Caulis Akebiae 7 parts, Medulla Junci 7 parts, Fructus Alpiniae Oxyphyllae 7 parts, Rhizoma Acori Graminei 7 parts, the Radix Linderae 7 parts, Radix Bupleuri 7 parts, Semen Plantaginis 7 parts, Rhizoma Corydalis 7 parts, Rhizoma Dioscoreae 7 parts, Fructus Corni 7 parts, Radix Pittospori Glabrati 3 parts, Fructus Foeniculi 3 parts, succinum 3 parts, Sanguis Draxonis 3 parts.
3. the preparation method of the prostatitic Chinese medicine composition for the treatment of according to claim 1 and 2, is characterized in that: Chinese medicinal preparation method is routinely made and is suitable for medicinal oral drugs.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510135572.5A CN104645192A (en) | 2015-03-26 | 2015-03-26 | Chinese medicine composition for treating prostatitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510135572.5A CN104645192A (en) | 2015-03-26 | 2015-03-26 | Chinese medicine composition for treating prostatitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104645192A true CN104645192A (en) | 2015-05-27 |
Family
ID=53237161
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510135572.5A Pending CN104645192A (en) | 2015-03-26 | 2015-03-26 | Chinese medicine composition for treating prostatitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104645192A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106039184A (en) * | 2016-08-16 | 2016-10-26 | 黄绍华 | Traditional Chinese medicine for treating prostatitis |
| CN107496649A (en) * | 2017-09-12 | 2017-12-22 | 亳州学院 | A kind of herbal composite for being used to treat chronic prostatitis |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1951470A (en) * | 2006-09-30 | 2007-04-25 | 刘唐保 | Medicament for treating chronic prostatitis and prostatic hyperplasia |
| CN101306119A (en) * | 2007-05-17 | 2008-11-19 | 杨惠忠 | Nicandra physalodes decoction for treating urgent, chronic prostate disease |
| CN102743567A (en) * | 2012-06-30 | 2012-10-24 | 张晨 | Traditional Chinese medicine for treating chronic prostatitis |
| CN103007223A (en) * | 2012-11-22 | 2013-04-03 | 于海涛 | Traditional Chinese medicine for treating prostatosis |
| CN103656334A (en) * | 2012-09-17 | 2014-03-26 | 青岛信立德中药技术研究开发有限公司 | Traditional Chinese medicine for treating prostatitis |
| CN103800622A (en) * | 2014-02-28 | 2014-05-21 | 山东省千佛山医院 | Traditional Chinese medicament for treating prostatitis |
-
2015
- 2015-03-26 CN CN201510135572.5A patent/CN104645192A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1951470A (en) * | 2006-09-30 | 2007-04-25 | 刘唐保 | Medicament for treating chronic prostatitis and prostatic hyperplasia |
| CN101306119A (en) * | 2007-05-17 | 2008-11-19 | 杨惠忠 | Nicandra physalodes decoction for treating urgent, chronic prostate disease |
| CN102743567A (en) * | 2012-06-30 | 2012-10-24 | 张晨 | Traditional Chinese medicine for treating chronic prostatitis |
| CN103656334A (en) * | 2012-09-17 | 2014-03-26 | 青岛信立德中药技术研究开发有限公司 | Traditional Chinese medicine for treating prostatitis |
| CN103007223A (en) * | 2012-11-22 | 2013-04-03 | 于海涛 | Traditional Chinese medicine for treating prostatosis |
| CN103800622A (en) * | 2014-02-28 | 2014-05-21 | 山东省千佛山医院 | Traditional Chinese medicament for treating prostatitis |
Non-Patent Citations (3)
| Title |
|---|
| 刘斌: ""中医药治疗慢性前列腺炎的研究进展"", 《中西医结合研究》 * |
| 曹开镛等主编: "《男性基础与临床》", 30 April 1996, 中国科学技术出版社 * |
| 朱永康等主编: "《前列腺疾病中医治疗》", 31 May 2002, 江苏科学技术出版社 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106039184A (en) * | 2016-08-16 | 2016-10-26 | 黄绍华 | Traditional Chinese medicine for treating prostatitis |
| CN107496649A (en) * | 2017-09-12 | 2017-12-22 | 亳州学院 | A kind of herbal composite for being used to treat chronic prostatitis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103386086A (en) | Traditional Chinese medicine composition for treating dysmenorrhea and preparation method thereof | |
| CN103316174B (en) | Traditional Chinese medicinal composition for treating acute cholecystitis and preparation method thereof | |
| CN103330920B (en) | Traditional Chinese medicine composition for curing oviduct obstruction | |
| CN103393913B (en) | Chinese medicinal composition for treating uterine prolapse | |
| CN103356968B (en) | Traditional Chinese medicine composition for treating endometriosis | |
| CN101406632A (en) | Medicament for treating rheumatism and rheumatoid and preparation thereof | |
| CN104645192A (en) | Chinese medicine composition for treating prostatitis | |
| CN104027461A (en) | Traditional Chinese medicine composition for treating urticaria | |
| CN103800843A (en) | Traditional Chinese medicine composition for treating chronic pelvic inflammation | |
| CN103784804A (en) | Pharmaceutical composition for treating benign prostatic hyperplasia | |
| CN105194584A (en) | Medicine for treating dysmenorrhea | |
| CN104873706A (en) | Traditional Chinese medicine composition for treating uterine cold infertility | |
| CN103356925A (en) | Traditional Chinese medicine composition for treating sperm non-liquified symptom | |
| CN101972458B (en) | Medicament for treating chronic rhinosinusitis | |
| CN104162043A (en) | Traditional Chinese medicine used for treatment of allergic nodular cutaneous vasculitis | |
| CN110403992A (en) | A kind of Chinese medicine composition of external application for curing diarrhea and preparation method thereof, purposes | |
| CN103356963B (en) | Traditional Chinese medicine composition for treating infertility | |
| CN101966329A (en) | Medicament for treating rash | |
| CN101979073A (en) | Medicament for soothing liver and regulating Qi | |
| CN102370867A (en) | Chinese medicinal prescription for treating postnatal constipation | |
| CN103800761A (en) | Traditional Chinese medicine composition for treating cervicitis | |
| CN104873882A (en) | Traditional Chinese medicine for treating jaundice hepatitis | |
| CN102363015B (en) | Compound detoxifying pill | |
| CN104189624A (en) | Traditional Chinese medicine for treating pelvic inflammation | |
| CN104800391A (en) | Traditional Chinese medicine for treating hepatitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150527 |
|
| RJ01 | Rejection of invention patent application after publication |